[1] 中华医学会妇产科学分会子宫内膜异位症协作组. 子宫内膜异位症的诊治指南[J]. 中华妇产科杂志, 2015, 50(3):161-169. [2] Giudice L C. Clinical practice. Endometriosis[J]. New England Journal of Medicine, 2010, 362(25):2389-2398. [3] Von T P, Cottenet J, Iacobelli S, et al. Epidemiology of Endometriosis in France: A Large, Nation-Wide Study Based on Hospital Discharge Data[J]. Biomed Research International, 2016, 2016(5):1-6. [4] Vercellini P, Viganò P, Somigliana E, et al. Endometriosis: pathogenesis and treatment[J]. Nature Reviews Endocrinology, 2014, 10(5):261-275. [5] 陆海英. 孕三烯酮治疗子宫内膜异位症对患者血清FSH、E2、LH及PROG的影响 [J]. 河北医药, 2016, 38(7):1021-1023. [6] 王麟淞, 王秀丽. 中重度子宫内膜异位症术后应用孕三烯酮治疗的效果评价[J]. 中国妇幼保健, 2014, 29(18):2864-2866. [7] Belsey E M, Machin D, D’Arcangues C. The analysis of vaginal bleeding patterns induced by fertility regulating methods. World Health Organization Special Programme of Research, Development and Research Training in Human Reproduction[J]. Contraception, 1986, 34(3):253-260. [8] 仝佳丽. 子宫内膜异位症的在位内膜病变研究进展[J]. 现代妇产科进展, 2010, 19(6): 465-467. [9] Matsuzaki S, Darcha C. Co-operation between the AKT and ERK signaling pathways may support growth of deep endometriosis in a fibrotic microenvironment, in vitro[J]. Human Reproduction, 2015, 30(7):1606-1616. [10] Kim J J, Kurita T, Bulun S E. Progesterone action in endometrial cancer, endometriosis, uterine fibroids, and breast cancer[J]. Endocrine Reviews, 2013, 34(1):53-85. [11] Mu L, Ma Y Y. Expression of focal adhesion kinase in endometrial stromal cells of women with endometriosis was adjusted by ovarian steroid hormones[J]. International Journal of Clinical & Experimental Pathology, 2014, 8(2):1810-1815. [12] Zhang H, Li J, Sun W, et al. Hyaluronic Acid-Modified Magnetic Iron Oxide Nanoparticles for MR Imaging of Surgically Induced Endometriosis Model in Rats[J]. Plos One, 2014, 9(4):e94718. [13] Delvoux B, D’Hooghe T, Kyama C, et al. Inhibition of typel 17β-hydroxysteroid dehydrogenase impairs the synthesis of 17β-estradiol in endometriosis lesions[J]. Journal of Clinical Endocrinology & Metabolism, 2014, 99(1):276-284. [14] Streuli I, de Ziegler D, Santulli P, et al. An update on the pharmacological management of endometriosis[J]. Expert Opin Pharmacother, 2013, 14(3):291-305. [15] Wang X D, Chen Y, Pei-Lin L I. Effect of gestrinone combined with menotrophin on sex hormones and pregnancy rate of patients with endometriosis[J]. Maternal & Child Health Care of China, 2014, 29(22):3614-3616. [16] Carp H J A, Soriano D, Zolti M. Progestogens and Endometriosis[M]// Progestogens in Obstetrics and Gynecology. Springer International Publishing, 2015:129-147. [17] 邱琳, 邓姗. 孕三烯酮治疗子宫内膜异位症效果及不良反应的Meta分析[J]. 国际妇产科学杂志, 2013, 40(5):451-459. |